When Is Prevention More Profitable than Cure? The Impact of Time-Varying Consumer Heterogeneity

Michael Kremer and Christopher Snyder

No 18862, NBER Working Papers from National Bureau of Economic Research, Inc

Abstract: We argue that in pharmaceutical markets, variation in the arrival time of consumer heterogeneity creates differences between a producer's ability to extract consumer surplus with preventives and treatments, potentially distorting R&D decisions. If consumers vary only in disease risk, revenue from treatments--sold after the disease is contracted, when disease risk is no longer a source of private information--always exceeds revenue from preventives. The revenue ratio can be arbitrarily high for sufficiently skewed distributions of disease risk. Under some circumstances, heterogeneity in harm from a disease, learned after a disease is contracted, can lead revenue from a treatment to exceed revenue from a preventative. Calibrations suggest that skewness in the U.S. distribution of HIV risk would lead firms to earn only half the revenue from a vaccine as from a drug. Empirical tests are consistent with the predictions of the model that vaccines are less likely to be developed for diseases with substantial disease-risk heterogeneity.

JEL-codes: D42 I18 L11 O31 (search for similar items in EconPapers)
Date: 2013-03
New Economics Papers: this item is included in nep-hea
Note: EFG EH
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (4)

Published as Preventives Versus Treatments* Michael Kremer and Christopher M. Snyder The Quarterly Journal of Economics (2015) 130 (3): 1167-1239. doi: 10.1093/qje/qjv012

Downloads: (external link)
http://www.nber.org/papers/w18862.pdf (application/pdf)

Related works:
Working Paper: When Is Prevention More Profitable than Cure? The Impact of Time-Varying Consumer Heterogeneity (2013)
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nbr:nberwo:18862

Ordering information: This working paper can be ordered from
http://www.nber.org/papers/w18862

Access Statistics for this paper

More papers in NBER Working Papers from National Bureau of Economic Research, Inc National Bureau of Economic Research, 1050 Massachusetts Avenue Cambridge, MA 02138, U.S.A.. Contact information at EDIRC.
Bibliographic data for series maintained by ().